Atlas Trials

An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma

Clinical trial NCT07399821 · RECRUITING

Trial details

NCT number
NCT07399821
Sponsor
Princess Maxima Center for Pediatric Oncology
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2025-11-05
Primary completion
2027-04-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.